Research Facility : Medical Research Center

Mission

To accelerate indigenous innovations and Leads to clinical advancement by Leveraging state-of-the-art facilities, pioneering therapies,and comprehensive research methodologies, while maintaining the highest standards of healthcare research for national and global health solutions.

Vision

To support and facilitate indigenous innovations, transforming them into groundbreaking clinical advancements through cutting-edge research facilities andstrong connections with fundamental science.

Mandate

To conduct human studies to validate and advance the discoveries made in our laboratories.

By translating pre-clinical findings into clinical applications, MRC aims to ensure the safety, efficacy, and real-world impact of innovative therapies and medical products, which can then be further scaled up by industry partners.

 

Expertise Area

 

FOLLOW-UP OBSERVATIONAL STUDIES AND CLINICAL TRIALS

• CORNERSTONE OF MRC: Designs, implements, and plans analyses for evaluating products developed under various TRFs, ensuring robust study outcomes.
• BRIDGES ACADEMIAAND INDUSTRY: Conducts prospective cohort studies and phase 1 trials, reducing the risk for industry partners to scale up validated products.
• COMPREHENSIVE DATA COLLECTION: Collects extensive data on long-term health outcomes, supporting evidence-based decisions.

CELL AND GENE THERAPY LAB

• EVALUATING SAFETY: Assesses the safety of CART-cell and other cell based therapies developed at THSTI, ensuring they meet rigorous standards.
• INDUSTRY COLLABORATION: Provides evaluated candidates for industry partners to scale up, facilitating commercialisation.

CONTROLLED HUMAN INFECTION STUDIES

• UNIQUE FACILITY: One-of-its-kind facility in the country to evaluate vaccines and drugs through controlled human infection studies.
• ACCELERATING TRANSLATION: Provides a platform to accelerate the development of vaccines and drugs for infectious diseases.
• RAPID TESTING: Facilitates quick and controlled evaluation of therapeutic candidates.

CLINICAL DEVELOPMENT SERVICES AGENCY (CDSA)

• CDSA helps to develop clinical products and build capacity for clinical research.
• COMPREHENSIVE CLINICAL RESEARCH SUPPORT: CDSA provides end-to-end clinical study support, encompassing every stage of clinical research
• TRAINING AND CAPACITY BUILDING: CDSA helps in building research capacity through high-quality training programs in clinical development, clinical trials, and regulations.

CLINICAL PHARMACOLOGY SERVICES (SAFETY AND DOSE-FINDING STUDIES)

• SAFETY AND EFFICACY: Evaluates the safety and efficacy of new drugs through pharmacokinetics and pharmacodynamics studies.
• CLINICAL TRIAL PREPARATION: Lays groundwork for clinical trials with new drug molecules.

ARTIFICIAL INTELLIGENCE-BASED IMAGING LAB

• Al MODELS: Develops Al models in external cohorts for accurate diagnosis, monitoring, and prognosis.
• SOFTWARE DEVELOPMENT: Builds applications incorporating validated Al models for clinical use.

 

Contact Details

Dr. Amit Awasthi / Dr Nitya Wadhwa
 aawasthi@thsti.res.in / nitya.wadhwa@thsti.res.in
 0129- 2876482 / 342